Animation
The promise and progress of cell-based therapies expanding around the globe can leave hospital cell collections teams facing competing priorities — and pressured to meet demand for your ongoing research and therapy development. Our experts help hospital staff standardize collections and adapt protocols for specific needs, so they have the resources to provide excellent patient care and a consistent supply of high-quality cells.
See how Veda Insights can help streamline apheresis.
Presentation
As cell and gene therapies gain traction around the globe, biotech and life science researchers and hospital cell collection teams have a vested common interest: ensuring the highest-quality starting materials with minimal variability for the greatest chance of therapeutic success. Optimizing collections comes down to three key points that play out across the cell collections ecosystem.
Discover how the pieces fit together.
Every research and cell therapy process and endpoint come with specific requirements, but no two patients are exactly alike. For too long, this perceived conflict has prevented biotech and life science organizations from sourcing cell products that truly meet their needs. That’s all changing thanks to the power of data analytics unlocking key insights from apheresis procedure data. Our Spectra Optia Prediction Algorithm service, which sets cell collection targets against benchmarks based on an individual patient’s precount, is just one example of how process standardization can boost overall quality and consistency as it helps improve patient experience.
Find out the difference analytics can make.
Industry Guide
Apheresis is key to the promise of cell-based therapies, and technological advancements are stretching cell collection capabilities to new heights. Apheresis has become an intelligent, data-driven, highly customizable process that can adapt to meet your specific needs — if you know how to optimize parameters and unlock the opportunities in data analytics. Elizabeth Valdez of Novartis explores various aspects of cell collections in great depth in content co-written with our own experts Erin Goodhue and Dalip Sethi.
See Chapter 5, "Cell Collection and Starting Materials Consideration," in this industry guide.
All products and solutions may not be available in all regions. Contact your Terumo Blood and Cell Technologies representative.